Yixuan Wang Selected Research

Proteasome Inhibitors

1/2023	Deacetylation induced nuclear condensation of HP1γ promotes multiple myeloma drug resistance.
11/2022	Hypoxia induces chemoresistance to proteasome inhibitors through orchestrating deSUMOylation and ubiquitination of SRC-3 in multiple myeloma.
1/2022	Epigenomic reprogramming via HRP2-MINA dictates response to proteasome inhibitors in multiple myeloma with t(4;14) translocation.
1/2021	DKK1 activates noncanonical NF-κB signaling via IL-6-induced CKAP4 receptor in multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yixuan Wang Research Topics

Disease

55	Neoplasms (Cancer) 01/2024 - 03/2011
11	Inflammation (Inflammations) 07/2023 - 01/2015
10	Neoplasm Metastasis (Metastasis) 02/2023 - 11/2017
9	Infections 05/2024 - 04/2016
8	Multiple Myeloma 04/2024 - 01/2021
8	Breast Neoplasms (Breast Cancer) 01/2024 - 03/2011
8	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 06/2012
7	Glioma (Gliomas) 12/2023 - 01/2021
7	Stomach Neoplasms (Stomach Cancer) 12/2023 - 02/2018
7	Osteoporosis 07/2023 - 10/2018
7	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2021
5	Chronic Hepatitis B 05/2024 - 01/2022
5	Hypoxia (Hypoxemia) 03/2024 - 01/2017
5	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2015
5	Parkinson Disease (Parkinson's Disease) 01/2024 - 01/2015
5	Carcinogenesis 11/2023 - 01/2016
5	COVID-19 01/2023 - 01/2020
5	Colitis 01/2023 - 01/2018
4	Disease Progression 10/2023 - 01/2021
4	Hypertension (High Blood Pressure) 05/2023 - 01/2014
4	Dementia (Dementias) 01/2023 - 01/2015
4	Carcinoma (Carcinomatosis) 01/2023 - 05/2019
4	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 01/2017
3	Bites and Stings (Sting) 01/2024 - 02/2022
3	Cough 01/2024 - 01/2020
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2023 - 01/2017
3	Atherosclerosis 07/2023 - 01/2023
3	Cognitive Dysfunction 01/2023 - 01/2016
3	Heart Failure 01/2023 - 01/2019
3	Dysbiosis 01/2023 - 01/2019
3	Pathologic Processes 06/2022 - 04/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 07/2017
2	Fever (Fevers) 05/2024 - 01/2023
2	Atrophy 12/2023 - 01/2023
2	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 01/2019
2	Genomic Instability 10/2023 - 01/2019
2	Hyperplasia 07/2023 - 05/2019
2	Arthritis (Polyarthritis) 05/2023 - 02/2021
2	Rheumatoid Arthritis 05/2023 - 05/2023
2	Muscular Atrophy (Muscle Atrophy) 05/2023 - 02/2021
2	Lymphatic Metastasis 02/2023 - 01/2017
2	Chronic Disease (Chronic Diseases) 01/2023 - 01/2022
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 12/2018
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2023

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2017
17	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2017
9	MicroRNAs (MicroRNA)IBA 05/2024 - 01/2016
8	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 01/2016
7	Long Noncoding RNAIBA 02/2023 - 10/2018
6	RNA (Ribonucleic Acid)IBA 01/2024 - 03/2021
6	CytokinesIBA 01/2024 - 10/2017
5	Transcription Factors (Transcription Factor)IBA 12/2023 - 01/2017
5	Antiviral Agents (Antivirals)IBA 01/2023 - 03/2015
5	Imiquimod (Aldara)FDA LinkGeneric 01/2023 - 08/2017
5	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2020
4	InterferonsIBA 01/2024 - 01/2022
4	Immune Checkpoint InhibitorsIBA 01/2024 - 08/2022
4	Apolipoproteins E (ApoE)IBA 01/2023 - 12/2022
4	Proteasome InhibitorsIBA 01/2023 - 01/2021
4	ChemokinesIBA 01/2023 - 01/2015
4	Messenger RNA (mRNA)IBA 04/2022 - 11/2020
4	AntigensIBA 01/2022 - 01/2020
3	AntibodiesIBA 01/2024 - 01/2021
3	CollagenIBA 10/2023 - 01/2023
3	Circular RNAIBA 09/2023 - 01/2020
3	NitrogenIBA 07/2023 - 01/2021
3	LipidsIBA 07/2023 - 10/2021
3	Phosphotransferases (Kinase)IBA 07/2023 - 12/2018
3	Therapeutic UsesIBA 01/2023 - 07/2020
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 06/2019
3	CholesterolIBA 01/2023 - 01/2022
3	VaccinesIBA 10/2022 - 01/2020
3	IronIBA 05/2022 - 01/2022
2	CystathionineIBA 01/2024 - 12/2013
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2024 - 01/2023
2	AlbuminsIBA 01/2024 - 01/2022
2	Triglycerides (Triacylglycerol)IBA 01/2024 - 01/2022
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2023 - 12/2023
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2023 - 01/2022
2	Protein Kinases (Protein Kinase)IBA 11/2023 - 07/2023
2	Bortezomib (Velcade)FDA Link 10/2023 - 01/2021
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2023 - 01/2022
2	CarrageenanIBA 05/2023 - 02/2021
2	KaolinIBA 05/2023 - 02/2021
2	GoldIBA 01/2023 - 04/2016
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 01/2018
2	ApolipoproteinsIBA 01/2023 - 12/2022
2	Dextran SulfateIBA 01/2023 - 03/2020
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 12/2018
2	CalciumIBA 01/2023 - 05/2019
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023 - 01/2023
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2022
2	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 01/2023
2	C-Reactive ProteinIBA 12/2022 - 01/2020

Therapy/Procedure

25	Therapeutics 01/2024 - 06/2012
9	Immunotherapy 12/2023 - 01/2022
7	Drug Therapy (Chemotherapy) 12/2023 - 01/2018
6	Heart Transplantation (Grafting, Heart) 01/2024 - 01/2020
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 02/2022
2	Transplantation 10/2023 - 01/2020